{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:55:34Z","timestamp":1791478534584,"version":"4.3.4"},"reference-count":96,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"DOI":"10.1080\/17512433.2026.2742316","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:19:31Z","timestamp":1791465571000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Limitations of current neuroprotective therapies in dementia with Lewy bodies"],"prefix":"10.1080","author":[{"given":"Deirdre M.","family":"O\u2019shea","sequence":"first","affiliation":[{"name":"University of Miami Miller School of Medicine","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanell","family":"Disla","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa E.","family":"Gosling","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German A.","family":"Valdelamar","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Ioana Tolea","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Galvin","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine","place":["Boca Raton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001496"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0306-8"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1195227"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14808"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4564-06.2007"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0711-0"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx275"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300227200"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1520335113"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201003122"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.1925"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.001"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12814"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2023.2244425"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200048"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.052332"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00856-7"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0096-2"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0348-8"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2022.2032601"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2025.2562151"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000473"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00299-w"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00306-0"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00467-8"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-10623740\/v1"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009323"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-026-02065-w"},{"key":"e_1_3_7_33_1","unstructured":"ClinicalTrials.gov. A placebo-controlled double-blind parallel-group randomized study to evaluate the efficacy safety and tolerability of E2027 in subjects with dementia with Lewy bodies [Internet]. Bethesda (MD): National Library of Medicine (US); 2018 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03467152"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.12.005"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005010"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01198-3"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.12.020"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2024.36"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124245"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71004"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1163184"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.108020"},{"key":"e_1_3_7_43_1","unstructured":"CervoMed. CervoMed announces new clinical plasma biomarker and imaging data at AAIC 2026 for neflamapimod in the treatment of dementia with Lewy bodies (DLB) [Internet]. Boston (MA): CervoMed Inc.; 2026 [cited 2026 Jul 29]. Available from: https:\/\/ir.cervomed.com\/news-releases\/news-release-details\/cervomed-announces-new-clinical-plasma-biomarker-and-imaging\/"},{"key":"e_1_3_7_44_1","unstructured":"ClinicalTrials.gov. An open-label phase 2a clinical study of the P38 alpha kinase inhibitor neflamapimod in patients with dementia with Lewy bodies (DLB) [Internet]. Bethesda (MD): National Library of Medicine (US); 2025 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06815965"},{"key":"e_1_3_7_45_1","unstructured":"ClinicalTrials.gov. A randomized double blind placebo-controlled study to evaluate the impact of K0706 on safety tolerability pharmacokinetics and pharmacodynamics and clinical outcomes in dementia with Lewy bodies (DLB) [Internet]. Bethesda (MD): National Library of Medicine (US); 2019 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03996460"},{"key":"e_1_3_7_46_1","unstructured":"ClinicalTrials.gov. A clinical trial to demonstrate clinical efficacy on cognitive neuropsychiatric and functional outcomes of ambroxol in new and early patients with prodromal and mild dementia with lewybodies [Internet]. Bethesda (MD): National Library of Medicine (US); 2020 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04588285"},{"key":"e_1_3_7_47_1","unstructured":"ClinicalTrials.gov. Ambroxol as a novel disease modifying treatment for Lewy body dementia [Internet]. Bethesda (MD): National Library of Medicine (US); 2020 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04405596"},{"key":"e_1_3_7_48_1","unstructured":"Iranian Registry of Clinical Trials. To assess the effect of trehalose on cognitive abillity in patients with Lewy body dementia and evaluation of key proteins in the protein interaction network of LBD [Internet]. Iranian Registry of Clinical Trials; 2025 [cited 2026 Jul 30]. Available from: https:\/\/en.irct.ir\/trial\/82764"},{"key":"e_1_3_7_49_1","unstructured":"ClinicalTrials.gov. A randomized placebo-controlled double-blind study of ATH-1017 treatment in subjects with Parkinson\u2019s disease dementia or dementia with Lewy bodies [Internet]. Bethesda (MD): National Library of Medicine (US); 2021 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04831281"},{"key":"e_1_3_7_50_1","unstructured":"ClinicalTrials.gov. A randomized double blind placebo controlled clinical trial exploring the target engagement and tolerability of terazosin hydrochloride in patients with dementia with Lewy bodies [Internet]. Bethesda (MD): National Library of Medicine (US); 2021 [cited 2026 Jul 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04760860"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32944-3"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad192"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106010"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85456"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt192"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00364-w"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12296"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105281"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2012.10.007"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.012393"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24790"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609532200"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.08.076"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705154114"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00048"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12302"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02679-6"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24782"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1657"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129987"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209570"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01325-5"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2412-a"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1991.tb01616.x"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207755"},{"key":"e_1_3_7_76_1","unstructured":"CervoMed. CervoMed announces new data from phase 2b trial demonstrating neflamapimod\u2019s potential as a treatment for dementia with Lewy bodies [Internet]. Boston (MA): CervoMed Inc.; 2025 [cited 2026 Jul 29]. Available from: https:\/\/ir.cervomed.com\/news-releases\/news-release-details\/cervomed-announces-new-data-phase-2b-trial-demonstrating\/"},{"key":"e_1_3_7_77_1","volume-title":"Alzheimer\u2019s Association International Conference; July 12\u201315, 2026","author":"Botzung A","year":"2026","unstructured":"Botzung A, Hourregue C, Vrillon A, et al. Results of a phase 2 study of neflamapimod 80mg twice-daily in dementia with Lewy Bodies. In: Alzheimer\u2019s Association International Conference; July 12\u201315, 2026; London, (UK). Alzheimer\u2019s Association; 2026."},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199700112-00005"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.11.1356"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199700112-00003"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.1687"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.5_Suppl_6.10S"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb02542.x"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.930060208"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.11.022"},{"key":"e_1_3_7_88_1","unstructured":"Athira Pharma. Athira pharma announces encouraging results from SHAPE phase 2 clinical trial of fosgonimeton for the treatment of Parkinson\u2019s disease dementia and dementia with Lewy Bodies [Internet]. Athira Pharma Inc. 2023 [cited 2026 Jul 29]. Available from: https:\/\/www.globenewswire.com\/news-release\/2023\/12\/12\/2794592\/0\/en\/athira-pharma-announces-encouraging-results-from-shape-phase-2-clinical-trial-of-fosgonimeton-for-the-treatment-of-parkinson-s-disease-dementia-and-dementia-with-lewy-bodies.html"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000211390"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.05.004"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1395413"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209656"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214346"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70291"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-026-01241-8"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70134"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12334"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3181c72b5d"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2742316","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17512433.2026.2742316","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2742316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:22:40Z","timestamp":1791476560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2026.2742316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":96,"alternative-id":["10.1080\/17512433.2026.2742316"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2026.2742316","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}